Boston University Clinical and Translational Science Institute

波士顿大学临床与转化科学研究所

• 批准号: 10425240
• 负责人: MEGAN H BAIR-MERRITT
• 金额: $ 645.76万
• 依托单位: BOSTON UNIVERSITY MEDICAL CAMPUS
• 依托单位国家: 美国
• 财政年份: 2015
• 资助国家: 美国
• 起止时间: 2015-08-13 至 2025-03-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10425240
• 关键词: Academic Medical Centers; Address; Advocate; Basic Science; Boston; Caring; Clinical Research; Clinical Sciences; Clinical Trials; Clinical and Translational Science Awards; Collaborations; Communities; Cultural Diversity; Development; Diagnostic; Disadvantaged; Diverse Workforce; Environment; Ethnic Origin; Funding; Gender; Goals; Health; Health Sciences; Health system; Healthcare; Hospitals; Immigrant; Individual; Informatics; Infrastructure; Institutes; Insurance; Language; Learning; Longevity; Maintenance; Medicaid; Medical center; Methods; National Center for Advancing Translational Sciences; New England; Outcome; Participant; Patients; Performance; Persons; Physicians; Policy Maker; Population; Principal Investigator; Process; Provider; Public Policy; Race; Recording of previous events; Research; Research Infrastructure; Research Institute; Resources; Risk; Science; Scientist; Socioeconomic Status; Special Population; Substance Use Disorder; Training; Translational Research; Underinsured; United States National Institutes of Health; Universities; Veterans Hospitals; Vision; Workforce Development; catalyst; design; disorder control; distrust; empowered; ethnic diversity; health care disparity; health disparity; improved; inner city; innovation; low socioeconomic status; member; multidisciplinary; novel; novel strategies; patient population; programs; racial diversity; residence; safety net; tool

The Boston University Clinical and Translational Science Institute (BU CTSI) is an innovative CTSA clinical and translational research hub and catalyst for national CTSA network science. Boston University and partner, Boston Medical Center Health System (affiliate with Boston HealthNet, Boston Accountable Care Organization, VA Boston Health System, Edith Norse Rogers Veterans Hospital and the HealthCore/New England Research Institutes, Inc.) to comprise the members of the BU CTSI. We serve the largest URG and At Risk patient populations in New England. Our overarching theme is meant to emphasize our commitment to developing translational research infrastructure that is appropriate and innovative to meet the standards of the CTSA Network AND is uniquely designed to meet the needs and overcome the many barriers in partnering in research with patients at risk for poor health and outcomes. In order to address the health needs of these communities, the BU CTSI will support workforce development, collaboration across our stakeholders and integration of translational science across the lifespan of our Special Populations the through the development of a competent workforce, use of novel informatics, methods and processes that address disparities of health care. The BU CTSI Goals are: Aim 1. Discover, demonstrate, deploy and disseminate novel methods in training that will enhance our entire translational science workforce and create opportunities for advancement. Aim 2. Develop the most efficient, most representative clinical trials hub possible employing the integrated resources of all our partners. Aim 3. Effect meaningful multi-directional relationships among all our community stakeholders that strengthen collaborative translational research across the lifespan of our special populations and enable novel approaches to integrating research into health care. Aim 4. In collaboration with other CTSA hubs, discover, develop and disseminate innovative tools to improve research on treatments and diagnostics that address national health problems: The BU CTSI’s vision is to be the strongest possible advocate for, and participant in, translational research that serves the health needs of our diverse At Risk patient populations by working with our community to create unique resources that can be integrated with and distributed to the national CTSA network.

波士顿大学临床与翻译科学研究所(BU CTSI)是一家创新的CTSA临床和翻译科学研究所 翻译研究中心和国家CTSA网络科学的催化剂。波士顿大学及其合作伙伴， 波士顿医疗中心健康系统(波士顿医疗网络附属公司，波士顿责任护理组织， 弗吉尼亚州波士顿卫生系统、伊迪丝·诺斯·罗杰斯退伍军人医院和HealthCore/新英格兰研究 Institutes，Inc.)由BU CTSI的成员组成。我们为最大的URG和有风险的患者提供服务 新英格兰的人口。我们的首要主题是强调我们对发展的承诺 翻译研究基础设施是适当的和创新的，以满足 CTSA网络，专为满足以下需求而设计并克服许多障碍 与健康和结果不佳的风险患者合作进行研究。为了解决健康问题 为了满足这些社区的需求，BU CTSI将支持员工队伍发展，通过我们的 在我们特殊人群的整个生命周期中，利益相关者和翻译科学的整合 培养一支称职的劳动力队伍，使用新的信息学、方法和流程，以解决 卫生保健方面的差距。BU CTSI的目标是： 目标1.在培训中发现、示范、部署和传播新方法，以增强我们的 翻译科学劳动力和创造机会的进步。 目标2.开发最高效、最具代表性的临床试验中心，尽可能利用 我们所有合作伙伴的资源。 目标3.在我们所有社区利益相关者之间建立有意义的多方向关系，以加强 在我们特殊人群的整个生命周期内进行协作翻译研究，并支持新的方法 将研究整合到医疗保健中。 目标4.与其他CTSA中心合作，发现、开发和传播创新工具，以改进 针对国家健康问题的治疗和诊断研究： BU CTSI的愿景是成为翻译研究的最强有力的倡导者和参与者， 通过与我们的社区合作创建 可与国家CTSA网络整合并分发给国家CTSA网络的独特资源。